EDGAR Filing Documents for 0001140361-24-018027

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001140361-24-018027

Filing Date

2024-04-04

Accepted

2024-04-04 18:11:25

Documents

Period of Report

2024-04-02

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	form4.html	4
1	FORM 4	form4.xml	4	2995
	Complete submission text file	0001140361-24-018027.txt		4488

Mailing Address 524 BROADWAY NEW YORK NY 10013

Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ATAI LIFE SCIENCES N.V. WALLSTRASSE 16 BERLIN 2M 10179

Business Address

Type: 4 | Act: 34 | File No.: 001-40493 | Film No.: 24824270